The Journal of Continuing Education in Psychiatry, Volume 39, Issues 7-12

activity administration adverse reactions agranulocytosis akathisia alcohol alexithymia amitriptyline and/or ANGELES animals anorexia anticholinergic antipsychotic antipsychotic agents anxiety arrhythmias behavior blood blurred vision bottles of 100 brain brief CALIFORN capsules Cardiovascular chronic clinical clomipramine CME Evaluation Service Contraindications convulsions Cylert daily dose discontinued disorders disturbances dopamine receptors dosage doxepin drowsiness drug Dry mouth edema extrapyramidal symptoms females haloperidol hospital hypersensitivity hypotension imipramine imipramine pamoate increased individual initial leukopenia levels LIDONE molindone hydrochloride lithium long-term MAO inhibitors ment mental mesoridazine mg amitriptyline HCI mg/day molindone nausea Navane neuroleptics occur once-a-day Oral overdosage patients receiving perphenazine pharmacological phenothiazines physician physostigmine potential Precautions pregnancy prescribing information psychiatric psychosis psychosomatic psychosurgery psychotherapy psychotic recommended relationship reported response Ritalin schizophrenic seizures severe sexual side effects significant SINEQUAN studies suicide syndrome tablets tachycardia tardive dyskinesia therapeutic therapy thioridazine tion treatment TRIAVIL tricyclic antidepressant Univ urinary retention usually weight gain